BioTech Showcase: The Investor Conference for InnovatorsJanuary 9-11, 2023 San Francisco, CA
GBI is a full-service biopharmaceutical CDMO based in Florida that aims to eliminate manufacturing risk for companies developing complex biologic therapeutics.
Our responsive teams of experts across development, manufacturing, project management, and quality can leverage our many platforms to move your project forward on time and on budget.
With an extensive offering of development services, state-of-the-art manufacturing equipment, and project support, GBI is truly a full-service CDMO biologics partner. Our approach pairs our expert knowledge base with an open mind towards scientific discovery so that together we can develop an optimal way to make our systems work for you and your biologics project, no matter how complex it may be.
Our Single-Source Solution™
GBI’s Single-Source Solution™ offers a wide breadth of integrated CDMO biologics services that are specifically tailored to your needs during manufacturing strategy development. Regardless of your project’s stage, our slate of development and manufacturing services are available to help ensure that your project is completed efficiently and safely.Explore GBI's Manufacturing Services
Manufacturing Strategy Development
GBI’s manufacturing strategy development team will walk you through what needs to be done to keep your project on time, in compliance, and within budget.Learn More
Stay in the loop and feel comfortable knowing GBI’s expertise is keeping your project on track with our transparent and proactive approach to project management.Learn More
Regulatory & CMC Support
No matter where in the world you are, GBI brings expert support to help you quickly and effectively move your drug candidates through the regulatory application and review process.Learn More
Quality Control & Quality Assurance
Every one of our departments involved in cGMP manufacturing maintains a quality program that meets that department’s specific needs.Learn More
GBI will review your requirements and share our process development and manufacturing expertise to design the appropriate technical, quality, CMC, and regulatory strategies for your biopharmaceutical candidate.Learn More
GBI will help you face the unique challenges of producing and fully characterizing biosimilars.
GBI is strongly positioned for the growing focus in biopharmaceuticals on the development of complex biologics that allow the targeted delivery of products with multiple functionalities.
News and Resources
Goodwin Biotechnology, Inc. Is Now GBI!
Next-Generation Conjugate SummitFebruary 21-23, 2023 Boston, MA
BioProcess International US WestFebruary 27 – March 2, 2023 San Diego, CA
BioProcess InternationalSeptember 18-21, 2023 Boston, MA
World ADCOctober 2023 San Diego, CA
Vaccines Present a Novel Strategy for Opioid Overdose Prevention
Theranostic Manufacturing Solutions
Leveraging Experience to Reduce Timelines for IND-Enabling Activities
Goodwin Biotechnology Announces the Appointment of Darrin T. Schellin as Chief Executive Officer